Screener
Eligibility screening
Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
29 US sites in AR, CA, FL, IL +14
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.